PRQR ProQR Therapeutics N.V.
Healthcare$1.56+0.00%OpenMarket Cap: $164.9M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$3.63
Target (Median)
$3.75
Target Range
$2.00 - $5.00
Upside from current price: 131.9%
Rating Distribution
1 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-09 | Chardan Capital | maintain | Buy | Buy |
| 2025-11-04 | Chardan Capital | maintain | Buy | Buy |
| 2025-08-08 | Chardan Capital | maintain | Buy | Buy |
| 2025-06-27 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2025-06-27 | JMP Securities | maintain | Market Outperform | Market Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.60 | $17.0M | 4 |
| Sun Dec 31 | $-0.30 | $59.3M | 4 |
| Mon Dec 31 | $-0.31 | $72.0M | 2 |
| Tue Dec 31 | $0.03 | $137.6M | 2 |